The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)
NCT ID: NCT02809248
Last Updated: 2018-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2016-07-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The occurrence of a hyperplasia of neointima can be minimized by application of a coated stent and a concurrent safety four weekly dual thrombocytes therapy
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion
NCT02739685
Endovascular Repair of Descending Thoracic Aortic Aneurysms
NCT00802984
EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus
NCT02632292
Effects Branch PA Stenting d-TGA, ToF and TA
NCT05809310
Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis
NCT00837954
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
coated stent
the patient get a coated coronary stent implantation (ZES - zotarolimus eluting stent)
ZES
stent implantation (zotarolimus eluting stent)
uncoated stent
the patient get a uncoated coronary stent implantation (BMS - bare metal stent)
BMS
stent implantation (bare metal stent)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ZES
stent implantation (zotarolimus eluting stent)
BMS
stent implantation (bare metal stent)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient is planned a coronary stent implantation
* adults who are contractually capable and mentally able to understand and follow the instructions of the study personnel
* written informed consent prior to study participation
Exclusion Criteria
* pregnancy and breast-feeding
* acute cardiac syndrome
* contraindication against an intracardiac catheter
* persons in dependence from the sponsor or working with the sponsor
* participation in a parallel interventional clinical trial
* patient has been committed to an institution by legal or regulatory order
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RWTH Aachen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Becker, MD
Role: PRINCIPAL_INVESTIGATOR
Uniklinik RWTH Aachen, Med. Klinik I
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-123
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.